No benefit from mirtazapine for treating agitation in dementia

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	68
Number of pages	1
Journal	Drug and Therapeutics Bulletin
Volume	60
Issue number	5
DOIs	https://doi.org/10.1136/dtb.2022.000013
Publication status	Published - 2022

ASJC Scopus subject areas

@article{dd3882283ab84dafb4b996187aed0a87,

title = "No benefit from mirtazapine for treating agitation in dementia",

author = "S. Banerjee and J. High and S. Stirling",

year = "2022",

doi = "10.1136/dtb.2022.000013",

language = "English",

volume = "60",

pages = "68",

journal = "Drug and Therapeutics Bulletin",

issn = "0012-6543",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - No benefit from mirtazapine for treating agitation in dementia

AU - Banerjee, S.

AU - High, J.

AU - Stirling, S.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85129778746

U2 - 10.1136/dtb.2022.000013

DO - 10.1136/dtb.2022.000013

M3 - Comment/debate

C2 - 35277387

AN - SCOPUS:85129778746

SN - 0012-6543

VL - 60

SP - 68

JO - Drug and Therapeutics Bulletin

JF - Drug and Therapeutics Bulletin

IS - 5

ER -